Gates Foundation Trust’s Eastman Chemical EMN Stock Holding History

Gates Foundation Trust’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,000	Closed	-$1.92M	–	40
2023 Q3	$1.92M	Buy	+25,000	New	+$2.07M	﹤0.01%	64

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Trust's EMN Position: Q4 2023 in Review

Gates Foundation Trust sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 25,000 shares — an estimated $1.92M sold.

Gates Foundation Trust first reported a position in EMN in Q3 2023 and held it in 1 quarter. The position peaked at $1.92M in Q3 2023. 711 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

Gates Foundation Trust reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
Gates Foundation Trust sold 25,000 Eastman Chemical shares in Q4 2023, an estimated $1.92M.
Gates Foundation Trust first reported a position in Eastman Chemical in Q3 2023 and held it in 1 quarter.
Gates Foundation Trust's Eastman Chemical position peaked at $1.92M in Q3 2023.
711 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on Gates Foundation Trust's 13F filing for Q4 2023, filed 14 Feb 2024.